Dilemma and strategy of minimally invasive nephron-sparing surgery for cystic renal cell carcinoma
-
摘要: 囊性肾癌是一类低度恶性潜能的复杂性肾肿瘤,约占肾脏肿瘤的4%。囊性肾癌的保肾手术挑战大,其囊壁薄,术中易破溃导致肿瘤细胞外溢可能,很难达到保肾手术的无瘤原则。本中心通过结合术前智能三维重建、解剖程序化操作、早期开放缝合技术等多种创新技术及方案,提高了囊性肾癌保肾手术的安全性和可行性。本文将从囊性肾癌的微创保肾手术角度,阐述囊性肾癌的术前评估、术中难点、术中技巧等方面,结合国内外文献及本中心诊疗经验进行深入探讨。Abstract: Cystic renal cell carcinoma is a complex renal tumor with a low-grade malignancy potential, accounting for approximately 4% in all kidney tumors. Nephron-sparing surgery for cystic renal cell carcinoma is challenging. It is easy to rupture during surgery, leading to the possibility of tumor cell extravasation, because the cyst wall is thin. It is difficult to achieve the tumor-free principle of nephron-sparing surgery. Our center has improved the safety and feasibility of nephron-sparing surgery for cystic renal cell carcinoma by combining various innovative technologies and solutions such as preoperative intelligent 3D reconstruction, anatomical procedure surgery, and early unclamping technology. From the perspective of minimally invasive nephron-sparing surgery for cystic renal cell carcinoma, this article describes the preoperative evaluation, intraoperative difficulties, and intraoperative skills of cystic renal cell carcinoma, and conducts in-depth discussions based on literature and our center's experience.
-
Key words:
- cystic renal cell carcinoma /
- nephron-sparing surgery /
- surgical strategy
-
表 1 Bosniak分级的2005版与2019版
级别 2005版Bosniak分级 2019版Bosniak分级 Ⅰ 发丝样薄壁;均匀水样密度,囊内无分隔、钙化、实性成分;无强化(单纯囊肿)。 边界清晰,壁薄(≤2 mm)且光滑;均匀单纯液体密度(-9~20 HU);无分隔、钙化;囊壁可强化。 Ⅱ 2种类型:①囊性病变伴少(1~3个)且薄的分隔,囊壁及分隔可强化,可被感知的强化;囊壁或分隔可伴细小钙化;②≤3 cm的均匀高密度病变,边缘光滑,无强化。 边界清晰,壁薄(≤2 mm)且光滑,分为6种类型:①囊内分隔少、薄,囊壁或分隔可出现可伴任意类型的钙化;②CT平扫上呈均匀高密度(≥70 HU);③病变均匀无强化,CT值>20 HU,可伴任意类型的钙化;④未行增强CT检查时,病变密度均匀,CT值-9~20 HU;⑤增强扫描实质期CT值为21~30 HU的均匀密度病变;⑥太小而无法定性的均匀低密度病变。 ⅡF 2种类型:①囊壁或分隔轻度增厚,囊内多发薄分隔伴或不伴可察觉但不可测量的强化,可有粗大或结节样钙化;②边界清晰的>3 cm的肾脏高密度病变,无强化。 囊壁光滑、略增厚(3 mm)且强化,或略增厚的1个或多个强化分隔又或多个(≥4个)强化的光滑、薄壁(≤2 mm)分隔。 Ⅲ 囊壁或分隔增厚或不规则,伴可测量的强化。 至少1个强化的厚壁(≥4 mm)或分隔,或者壁或分隔强化且不规则(出现≤3 mm与囊壁或分隔呈钝角的突起)。 Ⅳ 出现软组织成分,伴可测量的强化。 至少1个强化结节(≥4 mm与囊壁或分割呈钝角的突起,或者任意大小与囊壁或分隔呈锐角的强化突起)。 -
[1] Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. doi: 10.3322/caac.21660
[2] Wahal SP, Mardi K. Multilocular cystic renal cell carcinoma: a rare entity with review of literature[J]. J Lab Physicians, 2014, 6(1): 50-52. doi: 10.4103/0974-2727.129093
[3] Tse JR, Shen L, Shen J, et al. Prevalence of Malignancy and Histopathological Association of Bosniak Classification, Version 2019 Class Ⅲ and Ⅳ Cystic Renal Masses[J]. J Urol, 2021, 205(4): 1031-1038. doi: 10.1097/JU.0000000000001438
[4] Winters BR, Gore JL, Holt SK, et al. Cystic renal cell carcinoma carries an excellent prognosis regardless of tumor size[J]. Urol Oncol, 2015, 33(12): 505.e9-e13. doi: 10.1016/j.urolonc.2015.07.017
[5] Bosniak MA. The current radiological approach to renal cysts[J]. Radiology, 1986, 158(1): 1-10. doi: 10.1148/radiology.158.1.3510019
[6] Israel GM, Bosniak MA. An update of the Bosniak renal cyst classification system[J]. Urology, 2005, 66(3): 484-488. doi: 10.1016/j.urology.2005.04.003
[7] Yagisawa T, Takagi T, Yoshida K, et al. Surgical outcomes of robot-assisted laparoscopic partial nephrectomy for cystic renal cell carcinoma[J]. J Robot Surg, 2022, 16(3): 649-654. doi: 10.1007/s11701-021-01292-7
[8] 刘溪, 黄海, 潘秀武, 等. 3D打印联合术中超声定位内生型肾肿瘤在腹腔镜下保留肾单位手术中的应用[J]. 中华泌尿外科杂志, 2016, 37(11): 870. doi: 10.3760/cma.j.issn.1000-6702.2016.11.020
[9] 吕建敏, 潘秀武, 干思舜, 等. 三维智能定性定量分析系统在双肾肿瘤精准手术规划、模拟及实施中的应用效果分析[J]. 中华泌尿外科杂志, 2019, 40(5): 356-360. doi: 10.3760/cma.j.issn.1000-6702.2019.05.008
[10] 魏澎涛, 张寒, 李琦, 等. CT三维重建联合3D打印技术在腹腔镜下保留肾单位手术中的应用[J]. 临床泌尿外科杂志, 2020, 35(4): 304-306. https://www.cnki.com.cn/Article/CJFDTOTAL-LCMW202004011.htm
[11] 范宁, 张丽秀, 冯彬, 等. 3D打印技术辅助腹腔镜下肾部分切除术疗效的Meta分析[J]. 临床泌尿外科杂志, 2021, 36(7): 560-566. https://www.cnki.com.cn/Article/CJFDTOTAL-LCMW202107011.htm
[12] Campbell S, Uzzo RG, Allaf ME, et al. Renal Mass and Localized Renal Cancer: AUA Guideline[J]. J Urol, 2017, 198(3): 520-529. doi: 10.1016/j.juro.2017.04.100
[13] Pradere B, Peyronnet B, Delporte G, et al. Intraoperative Cyst Rupture during Partial Nephrectomy for Cystic Renal Masses-Does it Increase the Risk of Recurrence?[J]. J Urol, 2018, 200(6): 1200-1206. doi: 10.1016/j.juro.2018.06.025
[14] Chen SZ, Wu YP, Chen SH, et al. Risk factors for intraoperative cyst rupture in partial nephrectomy for cystic renal masses[J]. Asian J Surg, 2021, 44(1): 80-86. doi: 10.1016/j.asjsur.2020.03.006
[15] Ji C, Yang Y, Zhao X, et al. Laparoscopic Partial Nephrectomy for Peripelvic Cystic Renal Cell Carcinoma: A Single-Center Experience[J]. Urol Int, 2016, 97(2): 153-157. doi: 10.1159/000447598
[16] Zennami K, Takahara K, Matsukiyo R, et al. Long-term functional and oncologic outcomes of robot-assisted partial nephrectomy for cystic renal tumors: a single-center retrospective study[J]. J Endourol, 2021, 35(7): 1006-1012. doi: 10.1089/end.2020.0994
[17] Fan X, Xu K, Lin T, et al. Comparison of transperitoneal and retroperitoneal laparoscopic nephrectomy for renal cell carcinoma: a systematic review and meta-analysis[J]. BJU Int, 2013, 111(4): 611-621. doi: 10.1111/j.1464-410X.2012.11598.x
[18] 刘溪, 潘秀武, 杨启维, 等. 后腹腔镜下肾部分切除术治疗中度复杂性肾癌的方法改进及疗效分析(附84例报道)[J]. 临床泌尿外科杂志, 2016, 31(6): 533-537. https://www.cnki.com.cn/Article/CJFDTOTAL-LCMW201606011.htm
[19] 储传敏, 刘溪, 潘秀武, 等. 3D打印联合术中超声在腔镜下治疗完全内生型肾肿瘤中的应用(附15例报告)[J]. 第二军医大学学报, 2017, 38(8): 1065-1070. https://www.cnki.com.cn/Article/CJFDTOTAL-DEJD201708022.htm
[20] 吕建敏, 褚健, 张向民, 等. 腹腔镜下肾门部囊性肾癌肾部分切除术的应用研究[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2021, 15(5): 401-405.
[21] 李霖, 潘秀武, 崔心刚. 肾门肿瘤的腹腔镜手术难点和技巧改进[J]. 临床外科杂志, 2021, 29(2): 195-198. https://www.cnki.com.cn/Article/CJFDTOTAL-LCWK202102035.htm
[22] Zhang C, Li X, Yu W, et al. Ring suture technique in retroperitoneal laparoscopic partial nephrectomy for hilar cancer: a new renorrhaphy technique[J]. J Endourol, 2016, 30(4): 390-394. doi: 10.1089/end.2015.0691